The efficiency and safety of immune checkpoint inhibitors for advanced biliary tract cancers based on gene profiles: A retrospectively controlled study

Immune checkpoint inhibitors are potential agents to improve the survival of advanced biliary tract cancers (ABTCs). The current results are controversial because the predictors are imprecise. We present our primary experience with ABTCs based on gene landscape with exciting outcomes. ABTCs who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, G.L., Fan, Y.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478330/
https://www.ncbi.nlm.nih.gov/pubmed/36123922
http://dx.doi.org/10.1097/MD.0000000000030443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478330/
https://www.ncbi.nlm.nih.gov/pubmed/36123922
http://dx.doi.org/10.1097/MD.0000000000030443

Ejemplares similares